Excalipoint Therapetics
Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredMay 28, 2025 (18 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
JZ
Jielun Zhu Founder
Companies like Excalipoint Therapetics
BBoulevard Bio$65M Seed · Aug 2026
MModel Medicines$4.1M · Nov 2021
VVaderis Therapeutics$152M Series B+ · Aug 2026
DDraig Therapeutics$65M Series B+ · Jul 2026
LLoxagen
HHoloclara$16M Series A · Jun 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/excalipoint-therapetics (get a free API key).